TD has acquired Cowen Inc. Please bookmark TD Securities for further updates.

$74.9 Million

Apollo Endosurgery, Inc.

Follow-on Offering

Bookrunner, October 2021

Apollo Endosurgery, Inc.

Apollo Endosurgery, Inc. (“Apollo Endosurgery” or the “Company”) is a medical technology company primarily focused on the design, development and commercialization of innovative medical devices to advance gastrointestinal therapeutic endoscopy. The Company’s endoscopy product portfolio consists of the OverStitch Endoscopic Suturing System, X-Tack Endoscopic HeliX Tacking System and Orbera Intragastric Balloon. The Company’s products are used by gastroenterologists and bariatric surgeons in a variety of settings to treat multiple GI conditions.